Bad Pharma

Master case overview

Master file reference

GPRCC-ILL-2012-BG-821498

Illustrative status

Approved

Author / reference identity

Ben Goldacre

Subject area

Health & Medicine

Work

Bad Pharma

Review focus

Health evidence, reader framing and professional terminology. Program questions are selected for this subject area; no passage-level findings are asserted.

Proposed formats · scenario

Print and ebook

Proposed market scope · scenario

English-language release; foreign editions subject to separate review

Book release date

25 September 2012
Publication history ↗

Registration date · illustrative

2 October 2012

Publication and registration basis

Bad Pharma: Title and author matched publication-history record. Original-language/edition differences are retained where specified. The modeled registration is seven days after release. Where a source gives only a month or year, dates are shown as a range rather than inventing a day.

Modeled review date

2 November 2012

Source basis

Library title, author, subject mapping and catalog program definitions; no manuscript examined.

Programs & status

This illustrative file covers 10 program records, 41 review controls and 0 open items. Select a program for its review details, document checklist and next action.

Program reference

GPRCC-ILL-2012-BG-821498-HMPC

Master file

GPRCC-ILL-2012-BG-821498

Review scope

Print and ebook

Evidence position

3 of 3 controls complete in scenario

Publication context

Bad Pharma by Ben Goldacre · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 3

1. HMPC-101

   Claim classification

   For the proposed scope of Bad Pharma, separate general discussion from diagnostic or treatment claims in the proposed scope. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

2. HMPC-103

   Professional review

   For the proposed scope of Bad Pharma, define the qualifications and scope needed for a proposed specialist review. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

3. HMPC-104

   Reader framing

   For the proposed scope of Bad Pharma, separate educational content from individualized advice. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 3

• Health claim classification ledgerCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: HMPC-101.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Specialist review briefCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: HMPC-103.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Reader information wording sheetCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: HMPC-104.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative

↑ Back to programs

Program reference

GPRCC-ILL-2012-BG-821498-FCRS

Master file

GPRCC-ILL-2012-BG-821498

Review scope

Print and ebook

Evidence position

4 of 4 controls complete in scenario

Publication context

Bad Pharma by Ben Goldacre · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 4

1. FCRS-101

   Claim inventory

   For the proposed scope of Bad Pharma, classify factual, historical and statistical claims selected for the review scope. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

2. FCRS-102

   Source traceability

   For the proposed scope of Bad Pharma, record author, date, edition and location of supporting references. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

3. FCRS-103

   Context and limitations

   For the proposed scope of Bad Pharma, retain qualifications and avoid widening conclusions beyond their sources. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

4. FCRS-104

   Data reproduction

   For the proposed scope of Bad Pharma, reconcile quoted figures with their source tables and units. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 4

• Claim-to-source ledgerCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: FCRS-101.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Source bibliography and locator indexCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: FCRS-102.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Claim qualification scheduleCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: FCRS-103.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Statistical reproduction worksheetCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: FCRS-104.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative

↑ Back to programs

Program reference

GPRCC-ILL-2012-BG-821498-PFVR

Master file

GPRCC-ILL-2012-BG-821498

Review scope

Print and ebook

Evidence position

3 of 3 controls complete in scenario

Publication context

Bad Pharma by Ben Goldacre · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 3

1. PFVR-102

   Verification sources

   For the proposed scope of Bad Pharma, identify primary sources needed to verify each credential. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

2. PFVR-104

   Biography consistency

   For the proposed scope of Bad Pharma, align proposed retailer, jacket and speaker biographies. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

3. PFVR-105

   Currency checks

   For the proposed scope of Bad Pharma, identify which professional claims need date-sensitive confirmation. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 3

• Credential verification checklistCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: PFVR-102.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Biography comparison sheetCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: PFVR-104.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Credential currency scheduleCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: PFVR-105.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative

↑ Back to programs

Program reference

GPRCC-ILL-2012-BG-821498-AEPC

Master file

GPRCC-ILL-2012-BG-821498

Review scope

Print and ebook

Evidence position

4 of 4 controls complete in scenario

Publication context

Bad Pharma by Ben Goldacre · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 4

1. AEPC-101

   Promotional claims

   For the proposed scope of Bad Pharma, match proposed promotional language to documented support. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

2. AEPC-102

   Endorsement consent

   For the proposed scope of Bad Pharma, check scope and permission for any proposed blurb or endorsement. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

3. AEPC-103

   Material connections

   For the proposed scope of Bad Pharma, identify sponsorship disclosures that would be needed for the campaign. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

4. AEPC-105

   Campaign versions

   For the proposed scope of Bad Pharma, keep translated campaign copy aligned with the source version. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 4

• Advertising claim matrixCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: AEPC-101.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Endorsement permission checklistCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: AEPC-102.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Campaign disclosure scheduleCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: AEPC-103.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Campaign version registerCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: AEPC-105.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative

↑ Back to programs

Program reference

GPRCC-ILL-2012-BG-821498-IMRC

Master file

GPRCC-ILL-2012-BG-821498

Review scope

Print and ebook

Evidence position

3 of 3 controls complete in scenario

Publication context

Bad Pharma by Ben Goldacre · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 3

1. IMRC-101

   Fact and opinion boundaries

   For the proposed scope of Bad Pharma, separate editorial interpretation from independently checkable claims in proposed publicity. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

2. IMRC-102

   Non-affiliation wording

   For the proposed scope of Bad Pharma, review references to people and institutions for unintended endorsement implications. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

3. IMRC-103

   Interview preparation

   For the proposed scope of Bad Pharma, prepare source-backed responses and distinguish the author’s position from promotional paraphrases. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 3

• Publicity claim and source ledgerCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IMRC-101.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Non-affiliation wording sheetCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IMRC-102.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Interview and media briefingCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IMRC-103.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative

↑ Back to programs

Program reference

GPRCC-ILL-2012-BG-821498-IDLC

Master file

GPRCC-ILL-2012-BG-821498

Review scope

Print and ebook

Evidence position

5 of 5 controls complete in scenario

Publication context

Bad Pharma by Ben Goldacre · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 5

1. IDLC-101

   Agreement inventory

   For the proposed scope of Bad Pharma, identify proposed publisher, distributor and retail permissions for the named work. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

2. IDLC-102

   License boundaries

   For the proposed scope of Bad Pharma, map term, format, territory, language and sublicensing limits. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

3. IDLC-103

   Retail metadata

   For the proposed scope of Bad Pharma, reconcile title, author credit, edition description and rights-holder attribution. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

4. IDLC-104

   Accounting and reporting

   For the proposed scope of Bad Pharma, document royalty reporting intervals, deductions and audit provisions. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

5. IDLC-105

   Termination controls

   For the proposed scope of Bad Pharma, define takedown, stock sell-off and rights reversion responsibilities. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 5

• Distribution agreement inventoryCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IDLC-101.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Distribution license matrixCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IDLC-102.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Retail metadata approval sheetCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IDLC-103.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Royalty and reporting scheduleCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IDLC-104.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Termination and reversion checklistCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IDLC-105.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative

↑ Back to programs

Program reference

GPRCC-ILL-2012-BG-821498-IRTC

Master file

GPRCC-ILL-2012-BG-821498

Review scope

Print and ebook

Evidence position

5 of 5 controls complete in scenario

Publication context

Bad Pharma by Ben Goldacre · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 5

1. IRTC-101

   Chain of title

   For the proposed scope of Bad Pharma, identify the party authorized to grant rights and reconcile contributor assignments. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

2. IRTC-102

   Territory and format scope

   For the proposed scope of Bad Pharma, map languages, formats, exclusivity and reserved territories without assuming worldwide rights. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

3. IRTC-103

   Edition history

   For the proposed scope of Bad Pharma, separate original publication rights from revised-edition and supplementary-material rights. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

4. IRTC-104

   Quotation permissions

   For the proposed scope of Bad Pharma, record the basis for reuse of any third-party extracts in the proposed edition. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

5. IRTC-105

   Reversion and reservations

   For the proposed scope of Bad Pharma, identify expired grants, reserved uses and conflicting options. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 5

• Ownership and contributor assignment scheduleCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IRTC-101.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Territory, language and format matrixCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IRTC-102.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Edition and rights chronologyCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IRTC-103.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Third-party permissions registerCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IRTC-104.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Prior grants and reversion scheduleCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IRTC-105.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative

↑ Back to programs

Program reference

GPRCC-ILL-2012-BG-821498-CAVR

Master file

GPRCC-ILL-2012-BG-821498

Review scope

Print and ebook

Evidence position

5 of 5 controls complete in scenario

Publication context

Bad Pharma by Ben Goldacre · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 5

1. CAVR-101

   Visual asset provenance

   For the proposed scope of Bad Pharma, record the source and permitted use of cover and interior visual assets. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

2. CAVR-102

   Designer permissions

   For the proposed scope of Bad Pharma, separate designer deliverables from third-party stock and font licenses. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

3. CAVR-103

   Format reuse

   For the proposed scope of Bad Pharma, check proposed visual reuse across print, ebook, audio and promotion. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

4. CAVR-104

   Credit requirements

   For the proposed scope of Bad Pharma, record mandatory image credits and license conditions. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

5. CAVR-105

   Edition approval

   For the proposed scope of Bad Pharma, track the approved cover version for each proposed edition. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 5

• Cover and artwork provenance registerCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: CAVR-101.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Designer and supplier rights checklistCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: CAVR-102.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Visual reuse permission matrixCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: CAVR-103.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Visual credit-line sheetCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: CAVR-104.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Cover version approval logCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: CAVR-105.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative

↑ Back to programs

Program reference

GPRCC-ILL-2012-BG-821498-IBEM

Master file

GPRCC-ILL-2012-BG-821498

Review scope

Print and ebook

Evidence position

4 of 4 controls complete in scenario

Publication context

Bad Pharma by Ben Goldacre · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 4

1. IBEM-101

   Protected assets

   For the proposed scope of Bad Pharma, separate protectable text and artwork from third-party names and lawful references. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

2. IBEM-103

   Monitoring exclusions

   For the proposed scope of Bad Pharma, exclude commentary, criticism and other lawful references from proposed monitoring. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

3. IBEM-104

   Control verification

   For the proposed scope of Bad Pharma, identify who may authorize use of the proposed author and publication branding. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

4. IBEM-105

   Notice readiness

   For the proposed scope of Bad Pharma, specify evidence capture and rights-holder approval before any proposed notice. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 4

• Protected asset inventoryCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IBEM-101.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Monitoring keyword and exclusion planCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IBEM-103.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Brand and account control checklistCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IBEM-104.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Evidence capture and escalation protocolCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IBEM-105.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative

↑ Back to programs

Program reference

GPRCC-ILL-2012-BG-821498-AVRR

Master file

GPRCC-ILL-2012-BG-821498

Review scope

Print and ebook

Evidence position

5 of 5 controls complete in scenario

Publication context

Bad Pharma by Ben Goldacre · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 5

1. AVRR-101

   Audio grant

   For the proposed scope of Bad Pharma, separate narration and audio distribution rights from print rights. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

2. AVRR-102

   Performer agreement

   For the proposed scope of Bad Pharma, define narrator credit, recording use and permitted reuse. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

3. AVRR-103

   Audio-only material

   For the proposed scope of Bad Pharma, identify proposed introductions, music and other added audio assets. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

4. AVRR-104

   Pronunciation guidance

   For the proposed scope of Bad Pharma, prepare a subject-appropriate name and terminology pronunciation guide. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

5. AVRR-105

   Audio metadata

   For the proposed scope of Bad Pharma, align abridgment labels, credits and edition descriptions. Apply this check in the context of health evidence, reader framing and professional terminology.

   Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 5

• Audio rights matrixCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: AVRR-101.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Narrator agreement checklistCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: AVRR-102.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Audio asset permission registerCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: AVRR-103.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Pronunciation and production briefCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: AVRR-104.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative
• Audio edition metadata sheetCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: AVRR-105.Submission attempt 1 · 7 October 2012 · reviewed 2 November 2012 · illustrative

↑ Back to programs

Evidence and document index

A modeled evidence schedule for Bad Pharma. These are document requirements and scenario states, not uploaded attachments or manuscript citations.

Consolidated program status

Illustrative review history

Generated milestones showing how this workflow could progress; these events did not occur for the named author.

Program fee breakdown

The original illustrative case total is allocated across the 10 programs below. These example amounts are not payment receipts or quotations.

Total illustrative fees · USD$29,000

These restored case allocations are separate from the planning bands for new quotes. A written scope and quote determine the charge for an actual matter.

Next steps

1. Retain the edition, format and rights schedules modeled in this record.
2. Check proposed changes against each program’s maintenance standard.
3. Reassess new translations, licenses or substantial promotional changes before extending scope.

This sequence describes the modeled approved workflow only.